摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-溴四氢噻吩 1,1-二氧化物 | 14008-53-8

中文名称
3-溴四氢噻吩 1,1-二氧化物
中文别名
3-溴四氢噻吩1,1-二氧化物
英文名称
3-bromosulfolane
英文别名
3-bromothiolane 1,1-dioxide
3-溴四氢噻吩 1,1-二氧化物化学式
CAS
14008-53-8
化学式
C4H7BrO2S
mdl
MFCD00456581
分子量
199.068
InChiKey
IPOKQKBJDASROB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    46-47 °C
  • 沸点:
    355.3±35.0 °C(Predicted)
  • 密度:
    1.603 (estimate)
  • 物理描述:
    Solid

计算性质

  • 辛醇/水分配系数(LogP):
    0.6
  • 重原子数:
    8
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    42.5
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2934999090

制备方法与用途

类别:有毒物质

毒性分级:高毒

急性毒性:

  • 口服-大鼠 LD50: 215 毫克/公斤
  • 口服-小鼠 LD50: 121 毫克/公斤

可燃性危险特性:热分解排出有毒溴化物和硫氧化物烟雾

储运特性:

  • 库房通风、低温干燥
  • 与食品原料分开存放

灭火剂:泡沫、干粉、二氧化碳、雾状水

反应信息

  • 作为反应物:
    描述:
    3-溴四氢噻吩 1,1-二氧化物敌草腈 作用下, 以 四氢呋喃 为溶剂, 反应 4.0h, 以97%的产率得到2,3-二氢噻吩1,1-二氧化物
    参考文献:
    名称:
    Regiochemical and stereochemical studies on halocyclization reactions of unsaturated sulfides
    摘要:
    The regiochemistry and stereochemistry for the halocyclization reactions of unsaturated benzyl sulfides have been examined as a function of tether length, type of unsaturation (carbon-carbon double bond versus carbon-carbon triple bond), substituents, and halogenating agent. Alkenyl sulfides were found to react with iodine or bromine at room temperature to give five-membered ring cycloadducts exclusively over those having four-membered rings, while for larger systems, six-membered ring products are formed preferentially over their five-membered ring isomers and exclusively over the seven-membered ring adducts. The endo- versus exo-regioselectivity of these alkenyl sulfide ring closures most likely reflects the difference in thermodynamic stabilities of the beta-halo sulfide cycloadducts, which are able to equilibrate via a common episulfonium intermediate. The efficiency of the cyclization process markedly drops off for these alkenyl sulfides as the tether length increases beyond four intervening carbon centers. Thus, while the halogenations of 3-butenyl sulfides and 4-pentenyl sulfides give high yields of cycloadducts, those of 5-hexenyl sulfides afford only small amounts of cyclized products and large quantities of acyclic dibromides. Conversely the reactions of acetylenic sulfides with iodine give uniformly high yields and regiochemical control regardless of the tether length. Thus, 3-butynyl and 4-pentynyl sulfides cyclize cleanly to the five-membered ring while 5-hexynyl sulfides give exclusively the six-membered ring, The products arising from these alkynyl sulfide ring closures are believed to be formed under kinetic control. The methodology has been applied to the synthesis of unusual bicyclic beta-lactams related to the penicillin family of antibiotics.
    DOI:
    10.1021/jo00125a038
  • 作为产物:
    参考文献:
    名称:
    Regiochemical and stereochemical studies on halocyclization reactions of unsaturated sulfides
    摘要:
    The regiochemistry and stereochemistry for the halocyclization reactions of unsaturated benzyl sulfides have been examined as a function of tether length, type of unsaturation (carbon-carbon double bond versus carbon-carbon triple bond), substituents, and halogenating agent. Alkenyl sulfides were found to react with iodine or bromine at room temperature to give five-membered ring cycloadducts exclusively over those having four-membered rings, while for larger systems, six-membered ring products are formed preferentially over their five-membered ring isomers and exclusively over the seven-membered ring adducts. The endo- versus exo-regioselectivity of these alkenyl sulfide ring closures most likely reflects the difference in thermodynamic stabilities of the beta-halo sulfide cycloadducts, which are able to equilibrate via a common episulfonium intermediate. The efficiency of the cyclization process markedly drops off for these alkenyl sulfides as the tether length increases beyond four intervening carbon centers. Thus, while the halogenations of 3-butenyl sulfides and 4-pentenyl sulfides give high yields of cycloadducts, those of 5-hexenyl sulfides afford only small amounts of cyclized products and large quantities of acyclic dibromides. Conversely the reactions of acetylenic sulfides with iodine give uniformly high yields and regiochemical control regardless of the tether length. Thus, 3-butynyl and 4-pentynyl sulfides cyclize cleanly to the five-membered ring while 5-hexynyl sulfides give exclusively the six-membered ring, The products arising from these alkynyl sulfide ring closures are believed to be formed under kinetic control. The methodology has been applied to the synthesis of unusual bicyclic beta-lactams related to the penicillin family of antibiotics.
    DOI:
    10.1021/jo00125a038
点击查看最新优质反应信息

文献信息

  • [EN] 4, 6-DISUBSTITUTED 2-AMINO-PYRIMIDINES AS HISTAMINE H4 RECEPTOR MODULATORS<br/>[FR] 2-AMINO-PYRIMIDINES 4,6-DISUBSTITUÉES, CONVENANT COMME MODULATEURS DU RÉCEPTEUR H4 DE L'HISTAMINE
    申请人:INCYTE CORP
    公开号:WO2010075270A1
    公开(公告)日:2010-07-01
    The present invention relates to substituted heterocyclic compounds of Formula (I) or pharmaceutically acceptable salts or N-oxides or quaternary ammonium salts thereof wherein constituent members are provided hereinwith, as well as their compositions and methods of use, which are histamine H4 receptor inhibitors/antagonists useful in the treatment of histamine H4 receptor-associated conditions or diseases or disorders including, for example, inflammatory diseases or disorders, pruritus, and pain.
    本发明涉及式(I)的取代杂环化合物或其药用可接受的盐或N-氧化物或季铵盐,其中所述成员在此提供,并且它们的组合物和使用方法,这些化合物是组织胺H4受体抑制剂/拮抗剂,用于治疗组织胺H4受体相关疾病或疾病或疾病,例如,炎症性疾病或疾病,瘙痒和疼痛。
  • [EN] HETEROCYCLIC COMPOUNDS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES
    申请人:HOFFMANN LA ROCHE
    公开号:WO2022049134A1
    公开(公告)日:2022-03-10
    The invention provides new heterocyclic compounds having the general formula (I) wherein B, C, L, X, Y, RL and R3 to R5 are as described herein, compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds.
    该发明提供了具有一般式(I)的新杂环化合物,其中B、C、L、X、Y、RL和R3至R5如本文所述,包括这些化合物的组合物、制造这些化合物的方法以及使用这些化合物的方法。
  • Substituted Heterocyclic Compounds
    申请人:Zhang Colin
    公开号:US20100173901A1
    公开(公告)日:2010-07-08
    The present invention relates to substituted heterocyclic compounds of Formula I: or pharmaceutically acceptable salts or N-oxides or quaternary ammonium salts thereof wherein constituent members are provided hereinwith, as well as their compositions and methods of use, which are histamine H4 receptor inhibitors/antagonists useful in the treatment of histamine H4 receptor-associated conditions or diseases or disorders including, for example, inflammatory diseases or disorders, pruritus, and pain.
    本发明涉及式I的取代杂环化合物,或其药学上可接受的盐或N-氧化物或季铵盐,其中成分成员在此提供,以及它们的组合物和使用方法,这些方法是组胺H4受体抑制剂/拮抗剂,可用于治疗组胺H4受体相关的疾病或疾病或障碍,包括例如炎症性疾病或障碍,瘙痒和疼痛。
  • NOVEL [1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES
    申请人:Hoffmann-La Roche Inc.
    公开号:US20130137676A1
    公开(公告)日:2013-05-30
    The invention relates to a compound of formula (I) wherein A and R 1 to R 3 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.
    本发明涉及一种式子为(I)的化合物,其中A和R1到R3的定义如说明书和权利要求书中所述。该式(I)的化合物可用作药物。
  • [1,2,3]triazolo[4,5-D]pyrimidine derivatives
    申请人:HOFFMANN-LA ROCHE INC.
    公开号:US09056866B2
    公开(公告)日:2015-06-16
    The invention relates to a compound of formula (I) wherein A, R1 and R2 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.
    本发明涉及一种化合物,其化学式为(I),其中A、R1和R2的定义如说明书和权利要求中所述。化合物(I)可用作药物。
查看更多

同类化合物

苯甲酸,4-(1,3-二噁烷-2-基)- 甲基四氢-2-噻吩羧酸酯 环丁砜 烯丙基-(3-甲基-1,1-二氧代-四氢-1lambda*6*-噻吩-3-基)-胺 氯(四氢噻吩)金(I) 四甲基亚砜 四氢噻吩二醇 四氢噻吩-3-酮 四氢噻吩-3-羧酸-1,1-二氧 四氢噻吩-2,5-二酮 四氢噻吩-1,1-二亚基二胺 四氢噻吩 四氢-噻吩-3-醇 四氢-N-甲基-N-亚硝基-3-噻吩胺1,1-二氧化物 四氢-3-噻吩羧酸甲酯 四氢-3-噻吩羧酸 四氢-3-噻吩磺酰氯 1,1-二氧化物 四氢-3-噻吩硫醇1,1-二氧化物 四氢-3-噻吩甲酰氯1,1-二氧化物 四氢-3-噻吩甲腈1,1-二氧化物 四氢-3-噻吩基甲基丙烯酸酯 四氢-3,4-噻吩二胺1,1-二氧化物 四氢-2-噻吩羧酸 四亚甲基-D8砜 噻吩,四氢-2,2,5,5-四甲基- 八氟四氢噻吩 1,1-二氧化物 全氟四氢噻吩 二甲基砜茂烷 二氢-5,5-二甲基噻吩-3(2H)-酮 二氢-2-甲基-3(2H)-噻吩酮 乙基四氢-3-噻吩羧酸酯 Γ--硫代丁内酯 beta-乙基-beta-甲基-硫代丁内酯 alpha-乙基,alpha-甲基-硫代丁内酯 [[[(四氢噻吩1,1-二氧化物)-3-基]亚氨基]二(亚甲基)]二膦酸 [(1,1-二氧代四氢-3-噻吩基)甲基]胺 [(1,1-二氧代-3-四氢噻吩基)氨基]二硫代甲酸钾盐 N-烯丙基四氢-3-噻吩胺1,1-二氧化物 N-丁基-N-(1,1-二氧代四氢噻吩-3-基)胺盐酸盐 N-(1,1-二氧代四氢噻吩-3-基)乙酰胺 N'-(1,1-二氧代-四氢噻吩-3-基)-N,N-二甲基-乙烷-1,2-二胺 7-硫杂双环[2.2.1]庚-5-烯-2-羧酸 5-氧代四氢-2-噻吩羧酸 5-氧代-四氢噻吩-3-羧酸甲酯 5-[(1R,2S,5S)-7-氧代-3-硫杂-6,8-二氮杂双环[3.3.0]辛-2-基]戊酰胺 4a,8alpha-(甲桥硫代甲桥)萘10,10-二氧化物 4-肼基四氢噻吩-3-醇1,1-二氧化物 4-甲基氨基-1,1-二氧代-四氢-1lambda*6*-噻吩-3-醇 4-甲基-3-氧代四氢噻吩 4-溴二氢噻吩-3(2H)-酮 1,1-二氧化物